Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Fast and Accurate Diagnostic Test Introduced for Meningitis

By LabMedica International staff writers
Posted on 12 May 2009
A novel, fast-acting multiplex polymerase chain reaction (PCR) diagnostic technique simultaneously verifies a complex range of pathogens that indicate meningitis, a severely debilitating infection that if not diagnosed and treated quickly can result in death.

The Seeplex meningitis ACE detection tests for 12 meningitis-causing pathogens: five bacteria--Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, Listeria monocytogenes, and Streptococcus agalactiae; and seven viruses-- Herpes simplex virus 1 and 2 (HSV1, HSV2), varicella zoster virus (VZV, or human herpesvirus 3), Epstein-Bar virus (EBV, or human herpesvirus 4), Cytomegalovirus (CMV), human herpesvirus 6 (HHV6), and enteroviruses from cerebrospinal fluid (CSF).

Traditional methods of diagnosing meningitis rely on culture and Gram staining, both of which have notable performance limitations that can result in inaccurate diagnosis of meningitis. More...
Culture of CSF takes more than three days to obtain test results that can be unclear because of recent antibiotic use, contamination, or fastidious bacteria.

Gram staining is one of the oldest microbiologic tests that distinguish between Gram-positive and Gram-negative bacteria. But Gram staining does not identify the individual strain of bacteria. This type of detailed information is necessary for applying the correct antibiotics that can destroy certain meningitis causing bacteria, and prevent its spread to other people.

The World Health Organization (WHO; Geneva, Switzerland) estimates that 1.2 million cases of bacterial meningitis occur every year around the world, out of which 135,000 are fatal. The WHO postulates that a significant number of viral meningitis infections go undiagnosed in the absence of a standard diagnostic tool to determine the infections.

Seeplex technology is provided by Seegene (Seoul, Korea), a biotechnology company specialized in molecular diagnostics and research applications. "Seeplex Meningitis ACE detection provides accurate, rapid and cost-effective meningitis diagnostics. The test is a clear break from traditional methods of diagnosing meningitis, taking only six hours to detect either bacterial or viral meningitis infection in an easy to use testing format," said Dr. Jong-Yoon Chun, founder and CEO of Seegene. "This test will help to save lives and prevent unnecessary antibiotic prescriptions by providing precise information of meningitis causing pathogens at the earliest possible stage."

Related Links:

World Health Organization
Seegene



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.